Skip to main content
Equibles

Parallel Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1690010 SAN FRANCISCO, CA
Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$21,088,398
+$1,433,956 QoQ
Shares Held
83,035
+3.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#722
of 4,687 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $119,634,223 across 18 Drug Manufacturers - General names. JNJ ranks #3 (17.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 31,933 $38,301,401
2 ABBV
AbbVie Inc.
 100,846 $25,376,887
3 JNJ
Johnson & Johnson
This page 		83,035 $21,088,398
4 GILD
Gilead Sciences, Inc.
 76,862 $9,710,745
5 MRK
Merck & Co., Inc.
 66,774 $8,580,459
6 AMGN
Amgen Inc
 11,139 $4,033,654
7 NVO
Novo Nordisk A S
 56,877 $2,726,683
8 NVS
Novartis AG
 15,640 $2,451,100

All Filings in JNJ

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,088,398 83,035
2026-03-31 $19,654,442 80,406
2025-12-31 $16,440,108 79,440
2025-09-30 $13,993,091 75,467
2025-06-30 $11,128,906 72,857
2025-03-31 $12,636,178 76,195
2024-12-31 $10,480,756 72,471
2024-09-30 $12,630,308 77,936
2024-06-30 $10,536,235 72,087
2024-03-31 $12,584,172 79,551
2023-12-31 $10,674,620 68,104
2023-09-30 $11,661,002 74,870
2023-06-30 $12,016,752 72,600
2023-03-31 $10,500,010 67,742
2022-12-31 $10,350,100 58,591
2022-09-30 $9,183,772 56,218
2022-06-30 $9,981,564 56,231
2022-03-31 $9,199,300 51,906
2021-12-31 $8,171,500 47,767
2021-09-30 $7,973,578 49,372
2021-06-30 $7,495,340 45,498
2021-03-31 $6,505,466 39,583
2020-12-31 $5,449,912 34,629
2020-09-30 $5,475,508 36,778
2020-06-30 $5,122,166 36,423
2020-03-31 $4,820,601 36,762